281 related articles for article (PubMed ID: 26527536)
1. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
Savage KM; Stough CK; Byrne GJ; Scholey A; Bousman C; Murphy J; Macdonald P; Suo C; Hughes M; Thomas S; Teschke R; Xing C; Sarris J
Trials; 2015 Nov; 16():493. PubMed ID: 26527536
[TBL] [Abstract][Full Text] [Related]
2. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.
Sarris J; Byrne GJ; Bousman CA; Cribb L; Savage KM; Holmes O; Murphy J; Macdonald P; Short A; Nazareth S; Jennings E; Thomas SR; Ogden E; Chamoli S; Scholey A; Stough C
Aust N Z J Psychiatry; 2020 Mar; 54(3):288-297. PubMed ID: 31813230
[TBL] [Abstract][Full Text] [Related]
3. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
Sarris J; Stough C; Bousman CA; Wahid ZT; Murray G; Teschke R; Savage KM; Dowell A; Ng C; Schweitzer I
J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
[TBL] [Abstract][Full Text] [Related]
4. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
[TBL] [Abstract][Full Text] [Related]
5. Neuroimaging Insights: Kava's (
Savage K; Sarris J; Hughes M; Bousman CA; Rossell S; Scholey A; Stough C; Suo C
Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960239
[TBL] [Abstract][Full Text] [Related]
6. The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum.
Sarris J; Kavanagh DJ; Byrne G; Bone KM; Adams J; Deed G
Psychopharmacology (Berl); 2009 Aug; 205(3):399-407. PubMed ID: 19430766
[TBL] [Abstract][Full Text] [Related]
7. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop.
Thomsen M; Schmidt M
J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846
[TBL] [Abstract][Full Text] [Related]
8. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
Sarris J; LaPorte E; Schweitzer I
Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
[TBL] [Abstract][Full Text] [Related]
9. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
Volz HP; Kieser M
Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of kava in the treatment of anxiety disorders.
Singh YN; Singh NN
CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
[TBL] [Abstract][Full Text] [Related]
11. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
[TBL] [Abstract][Full Text] [Related]
12. Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients.
Boerner RJ; Sommer H; Berger W; Kuhn U; Schmidt U; Mannel M
Phytomedicine; 2003; 10 Suppl 4():38-49. PubMed ID: 12807341
[TBL] [Abstract][Full Text] [Related]
13. Kava for Generalized Anxiety Disorder: A Review of Current Evidence.
Ooi SL; Henderson P; Pak SC
J Altern Complement Med; 2018 Aug; 24(8):770-780. PubMed ID: 29641222
[TBL] [Abstract][Full Text] [Related]
14. The acute effects of kava and oxazepam on anxiety, mood, neurocognition; and genetic correlates: a randomized, placebo-controlled, double-blind study.
Sarris J; Scholey A; Schweitzer I; Bousman C; Laporte E; Ng C; Murray G; Stough C
Hum Psychopharmacol; 2012 May; 27(3):262-9. PubMed ID: 22311378
[TBL] [Abstract][Full Text] [Related]
15. Explanatory attributions of anxiety and recovery in a study of kava.
Abraham KC; Connor KM; Davidson JR
J Altern Complement Med; 2004 Jun; 10(3):556-9. PubMed ID: 15253862
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.
Pittler MH; Ernst E
J Clin Psychopharmacol; 2000 Feb; 20(1):84-9. PubMed ID: 10653213
[TBL] [Abstract][Full Text] [Related]
17. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
Gastpar M; Klimm HD
Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
[TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled study of Kava kava in generalized anxiety disorder.
Connor KM; Davidson JR
Int Clin Psychopharmacol; 2002 Jul; 17(4):185-8. PubMed ID: 12131602
[TBL] [Abstract][Full Text] [Related]
19. Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects.
Sarris J; Stough C; Teschke R; Wahid ZT; Bousman CA; Murray G; Savage KM; Mouatt P; Ng C; Schweitzer I
Phytother Res; 2013 Nov; 27(11):1723-8. PubMed ID: 23348842
[TBL] [Abstract][Full Text] [Related]
20. Kava extract for treating anxiety.
Pittler MH; Ernst E
Cochrane Database Syst Rev; 2003; 2003(1):CD003383. PubMed ID: 12535473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
